Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

New drug combination shrinks tumors in most pancreatic cancer patients

A new oral medication combined with standard chemotherapy shrank tumors in over 60 percent of advanced pancreatic cancer patients. Researchers presented these promising phase 1/2 clinical trial results at the EORTC-NCI-AACR Symposium in Barcelona on Friday. Specifically, the study tested a daily pill called daraxonrasib alongside two standard intravenous chemotherapy drugs, gemcitabine and…

We haven't written up this one. Daily Times has the full story — the link below goes straight to it.

Read the original at dailytimes.com.pk →

Report a problem with this story

More in Health & Medicine

More from Saturday 21 November →